Cell-mediated immunity of natural killer and CD8 cells

27,483views

Cell-mediated immunity of natural killer and CD8 cells

IMI

IMI

Lymphatic system anatomy and physiology
Introduction to the immune system
Innate immune system
T-cell development
B-cell development
B-cell activation, differentiation, and contraction
T-cell activation
B- and T-cell memory
Spleen histology
Thymus histology
Lymph node histology
Cytokines
Complement system
MHC class I and MHC class II molecules
VDJ rearrangement
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
X-linked agammaglobulinemia
DiGeorge syndrome
Adenosine deaminase deficiency
Severe combined immunodeficiency
Hyper IgM syndrome
Common variable immunodeficiency
Hyperimmunoglobulin E syndrome
Selective immunoglobulin A deficiency
IgG subclass deficiency
Isolated primary immunoglobulin M deficiency
Ataxia-telangiectasia
Wiskott-Aldrich syndrome
Chediak-Higashi syndrome
Complement deficiency
Hereditary angioedema
Chronic granulomatous disease
Leukocyte adhesion deficiency
Contracting the immune response and peripheral tolerance
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Systemic lupus erythematosus
Serum sickness
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Miscellaneous cell wall synthesis inhibitors
Mechanisms of antibiotic resistance
Clostridium perfringens
Clostridium tetani (Tetanus)
Bacillus anthracis (Anthrax)
Yersinia pestis (Plague)
Francisella tularensis (Tularemia)
Borrelia burgdorferi (Lyme disease)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Human papillomavirus
HIV (AIDS)
Borrelia species (Relapsing fever)
Pasteurella multocida
Bacteroides fragilis
Varicella zoster virus
Coxsackievirus
Human herpesvirus 6 (Roseola)
Rubella virus
Measles virus
Parvovirus B19
Human herpesvirus 8 (Kaposi sarcoma)
Viral exanthems of childhood: Pathology review
Nucleoside reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Herpesvirus medications
Integrase and entry inhibitors
Hepatitis medications
Neuraminidase inhibitors
Sensitivity and specificity
Positive and negative predictive value
Herpes simplex virus
Epstein-Barr virus (Infectious mononucleosis)
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Graft-versus-host disease
Contact dermatitis
Cytomegalovirus infection after transplant (NORD)
Bacterial structure and functions
Nocardia
Actinomyces israelii
Brucella
Mycobacterium leprae
Viral structure and functions
Cytomegalovirus
Poxvirus (Smallpox and Molluscum contagiosum)
Sporothrix schenckii
Candida
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Leishmania
Loa loa (Eye worm)
Onchocerca volvulus (River blindness)
Trichinella spiralis
Pediculus humanus and Phthirus pubis (Lice)
Sarcoptes scabiei (Scabies)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Protein synthesis inhibitors: Tetracyclines
Miscellaneous protein synthesis inhibitors
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Azoles
Echinocandins
Folliculitis
Erythema multiforme
Cellulitis
Impetigo
Erysipelas
Necrotizing fasciitis
Onychomycosis
Erythropoietin

Transcript

Watch video only

The key cells of the adaptive immune response are the lymphocytes - the B and T cells.

And there are two types of T cells.

Helper T cells which express CD4 on their surface, and cytotoxic T cells which express CD8 on their surface.

Helper T cells primarily support other immune cells, whereas cytotoxic T cells kill cells that are infected with a pathogen or are cancerous.

Cytotoxic T cells, along with natural killer cells, are part of cell mediated immunity.

Cell mediated immunity refers to the part of the immune response that’s based on cellular interactions, and cannot be transferred through serum from one person to another.

That makes sense since both natural killer and cytotoxic T cells need to interact directly with a target cell in order to destroy it.

Now, when a T cell is initially formed it’s considered naive.

Later when that T cell encounters an antigen in the lymph node- it gets activated or primed - and turns into an effector T cell.

This process of priming requires two signals.

The first signal is the antigen itself, which is usually presented on an MHC molecule on the surface of an antigen presenting cell like a macrophage or dendritic cell.

Cytotoxic T cells respond to intracellular antigens - like viruses, intracellular bacteria, and tumor antigens.

The naive cytotoxic T cell needs a high level of stimulation to become activated and it relies on a process called cross-presentation to reach that level.

In cross-presentation macrophages or dendritic cells take up the antigen and then present it to the cytotoxic T cell.

These antigens typically come from extracellular pathogens or from tumor cells or virally infected cells.

The first signal is that the antigen has to bind perfectly to the T cell receptor or TCR.

The second signal is called costimulation - and it’s when a ligand called CD28 on the surface of a T cell binds to a ligand called B7 on the antigen presenting cell.

This region, which includes the T cell receptor which binds to the MHC-Antigen, and CD8 and CD28 which bind with B7, is called the immune synapse.

Once the T cell receives both of these signals, a number of changes occur within the cell that transforms the naive T cell into a cytotoxic T cell.

The activated T helper cell also begins making lots of cytokine IL-2, and upregulates its IL-2 alpha receptor.

The IL-2 receptor has three protein components - alpha, beta, and gamma.

A naive T cell only expresses the beta and gamma components of the IL-2 receptor, but these have low affinity for IL-2, in contrast to the alpha component of the IL-2 receptor which has a high affinity for IL-2.

Using just the beta and gamma components is like trying to eat an apple with only your lips and tongue.

And upregulating the alpha component is like using your teeth to take a big bite out of the juicy apple - much more effective and satisfying!

As a result active T cells make more IL-2 and then bind to the IL-2 that they make with their IL-2 receptors - a form of autocrine stimulation - a cell stimulating itself.

In response to the IL-2, the activated T cell starts to rapidly undergo cell division - a process called clonal expansion.

The cytotoxic T cell is now a lean, mean, killing machine that’s ready to attack.

This activated cytotoxic T cell only needs to see its antigen in the context of MHC I in order to kill the cell.

In other words, it no longer needs that costimulatory signal from CD28.

And the way that cytotoxic T cells find potential targets is by going cell-to-cell binding non-specifically.

They use adhesion molecules like LFA-1 on their surface to bind to molecules like ICAM which is found on the surface of most cells.

After loosely binding in this way, it tries to bind to that cell’s MHC I molecule.

If the cytotoxic T cell cannot bind because the correct antigen isn’t present, then the cytotoxic T cell disengages and moves on to the next cell.

Key Takeaways

https://osmosis.org/learn/Cell-mediatedimmunityofnaturalkillerandCD8_cells

Natural killer cells are innate lymphocytes that play a critical role in the early response to viral infection and cancer. They detect virus-infected cells and eliminate them before they can spread the infection. CD8 cells are cytotoxic T lymphocytes that recognize and kill infected or mutated cells. CD8 cells also secrete cytokines that stimulate the immune response. Both natural killer cells and CD8 cells are essential in protecting against cancer and infections.